Natco Pharma Board Meeting Date

Capital Structure Change

Natco Pharma Capital Structure Change

Natco Pharma's ₹1,279.4 Crore rights issue closed on October 22, 2026. Shares were priced at ₹750 each on a ₹2 face value.

Value

₹1,279 Cr

Product LaunchAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Natco Pharma Product Launch

Natco Pharma launches Carboplatin Injection, a Paraplatin® generic, in the U.S. market via its subsidiary. The oncology product addresses a critical U.S. supply shortage.

Other Announcement

Natco Pharma Other Announcement

Natco Pharma Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026. This filing is a routine regulatory compliance submission.

Share Pledge

Natco Pharma Share Pledge

Promoter V.C. Nannapaneni pledged 850,000 shares of Natco Pharma, valued at ₹67.10 Crore. This pledge creation increases encumbrance on promoter shareholding.

Value

₹67.10 Cr

Fund RaiseAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Natco Pharma Fund Raise of ₹2,000 Cr

Natco Pharma shareholders approved fund raising of up to Rs. 2,000 Crore through various instruments, along with other routine AGM resolutions.

Value

₹2,000 Cr

Annual General Meeting

Natco Pharma Annual General Meeting

Natco Pharma held its 43rd Annual General Meeting on September 30, 2026. Shareholders approved all agenda items, including a fund-raising authorisation limit of Rs. 2,000 Crore.

Board Meeting DateRajasthan Cylinders & Containers Ltd RCCL

Rajasthan Cylinders & Containers Board Meeting Date

Rajasthan Cylinders & Containers intimated a board meeting on 05 November 2026 to approve unaudited results for quarter and half year ended 30 September 2026. The trading window stays closed until 07 November 2026.

Board Meeting DateJetking Infotrain Ltd JETKINGQ

Jetking Infotrain Board Meeting Date

Jetking Infotrain has scheduled a board meeting on November 4, 2026 to consider unaudited quarterly and half-year results. The trading window remains closed until 48 hours after the results announcement.

Board Meeting DateMetropolis Healthcare Ltd METROPOLIS

Metropolis Healthcare Board Meeting Date

Metropolis Healthcare intimated a board meeting on November 3, 2026 to consider Q2 and half-year unaudited results and possible interim dividend. Trading window is closed October 1 to November 5, 2026.

Board Meeting DateAelea Commodities Ltd 544213

Aelea Commodities Board Meeting Date

Aelea Commodities has scheduled a board meeting for 2 November 2026 to consider half-year results and other items. The agenda includes an additional independent director, a director resignation, and business expansion and capex.

Board Meeting DateR Systems International Ltd RSYSTEMS

R Systems International Board Meeting Date

R Systems International will hold a board meeting on 3 November 2026 to consider quarterly and nine-month results to September 2026. The trading window remains closed until 48 hours after the results are declared.

Board Meeting DateOnida Electronics Ltd ONIDA

Onida Electronics Board Meeting Date

Onida Electronics schedules a 3 November 2026 board meeting for Q2 and half-year results and ESOP share allotment. Trading window stays closed until 48 hours post-results.